U.S. Specialty Stores Stock News

JFrog Ltd. ( NASDAQ:FROG ) shares have continued their recent momentum with a 30% gain in the last month alone. Looking...

Amerant Bancorp Inc. ( NYSE:AMTB ) stock is about to trade ex-dividend in four days. Typically, the ex-dividend date is...

AMN Healthcare Services, Inc. ( NYSE:AMN ) defied analyst predictions to release its quarterly results, which were...

Crane (CR) just reported its third quarter earnings, revealing stronger sales and profit growth compared to last year. Alongside steady analyst sentiment, the company’s performance this quarter is attracting attention from investors. See our latest analysis for Crane. After a robust earnings report and solid dividend announcement, Crane's momentum has been on investors’ radar. The stock’s 1-month share price return was a healthy 8%, reflecting growing confidence, while its 1-year total...

Thermo Fisher Scientific (TMO) just announced a major new share repurchase plan, with board approval to buy back up to $5 billion of stock and no set end date. For investors, this is an important glimpse into management’s capital allocation plans and confidence. See our latest analysis for Thermo Fisher Scientific. This announcement follows a string of corporate updates from Thermo Fisher Scientific over the past few weeks. These include a new quarterly dividend payout and the debut of their...

Cushman & Wakefield recently reported strong third quarter results, with sales rising to US$2,605.9 million and net income reaching US$51.4 million, both up from the prior year. This performance highlights improved profitability and robust operational execution across Cushman & Wakefield’s global commercial real estate services platform. We'll explore how this improved earnings momentum shapes Cushman & Wakefield's investment narrative and outlook for further revenue growth. The latest GPUs...

Toast, Inc. recently reported third-quarter 2025 results, posting US$1.63 billion in revenue and US$105 million in net income, both up significantly from the previous year, and raised its full-year adjusted EBITDA guidance. An interesting development is that despite a miss on annual recurring revenue, Toast's strong profit performance and improved outlook were well received by investors. We'll explore how Toast's upgraded profit guidance following robust quarterly results shapes its...

Comstock Resources (CRK) grabbed investors’ attention with its third quarter results, showing a sharp financial turnaround. This improvement was driven by higher natural gas prices, careful cost control, and a significant asset sale that reduced long-term debt. See our latest analysis for Comstock Resources. After a rocky start to the year, Comstock Resources is catching strong momentum, with the share price jumping 47% over the past three months and total shareholder return topping 74% for...

It's been a mediocre week for Zymeworks Inc. ( NASDAQ:ZYME ) shareholders, with the stock dropping 14% to US$16.46 in...

Gaming and Leisure Properties, Inc. reported its third quarter 2025 results, posting higher sales, revenue, and net income compared to the prior year, while also announcing plans to acquire and fund the real estate for the upcoming Live! Casino and Hotel Virginia project. This dual announcement highlights the company’s ongoing growth through both robust financial performance and involvement in major gaming and hospitality developments. We’ll explore how Gaming and Leisure Properties’ recent...

CVB Financial Corp, through Citizens Business Bank, recently released its third quarter 2025 Form 10-Q highlighting stable financial metrics and effective cost management against an economic outlook of lower GDP growth and rising unemployment. A unique aspect from the report is the company's continued emphasis on credit quality management and loan portfolio diversification, aiming to mitigate credit risk during a potentially challenging economic period. We'll explore how CVB Financial's...

IMAX (NYSE:IMAX) has just wrapped up a $250 million convertible senior notes offering, channeling the funds to retire nearly all of its 2026 debt. This move increases balance sheet flexibility and supports IMAX’s continued investment in growth opportunities. See our latest analysis for IMAX. IMAX’s momentum this year has been hard to ignore, with a 37.32% year-to-date share price return and a substantial 41.60% total shareholder return over the past twelve months. Strategic moves like the...

Axos Financial (AX) delivered first quarter results that beat market expectations, supported by steady net interest margins, increased loan balances, and improving credit performance. Management’s focus on operational discipline continues to shape investor sentiment. See our latest analysis for Axos Financial. Axos Financial’s steady execution has caught the market’s attention, with the share price up 17.6% year-to-date and recent momentum building following the latest quarterly results...

LCI Industries (LCII) just posted its third quarter earnings, showing meaningful gains in both sales and net income compared to last year. The company also raised its October sales guidance to support a growth outlook. See our latest analysis for LCI Industries. LCI Industries’ upbeat earnings and stronger sales guidance appear to have energized its shares, with a 1-month share price return of 28% helping recapture lost ground. Despite a modest year-to-date move, the recent momentum contrasts...

Johnson & Johnson (JNJ) just received U.S. FDA approval for two new indications: DARZALEX FASPRO for high-risk smoldering multiple myeloma and CAPLYTA for major depressive disorder, adding to its growing lineup of specialty medicines. See our latest analysis for Johnson & Johnson. Johnson & Johnson’s momentum has been quietly gathering steam, with recent approvals for first-in-class therapies like DARZALEX FASPRO and CAPLYTA building investor optimism about its innovation engine. The...

Catalyst Pharmaceuticals (CPRX) shares drew fresh attention after the company reported an impressive third quarter. Revenue and earnings both climbed sharply year over year. Management also raised full-year revenue guidance, reinforcing confidence in future growth. See our latest analysis for Catalyst Pharmaceuticals. Momentum has picked up for Catalyst Pharmaceuticals in recent months, with third-quarter earnings, upbeat revenue guidance, and a new $200 million share buyback sparking...

NorthWestern Energy Group (NWE) has seen its stock price steadily climb, rising over 22% year-to-date. Investors are taking a closer look at what is driving this momentum and what it could mean going forward. See our latest analysis for NorthWestern Energy Group. NorthWestern Energy Group’s share price has surged over 22% so far this year, reflecting renewed optimism as investors respond to steady growth signals and a stronger outlook for the utility sector. This momentum is underscored by a...

NeoGenomics recently reported its third quarter 2025 results with sales of US$187.8 million, year-over-year revenue growth, and a wider quarterly net loss, while also reaffirming full-year guidance for both revenue and expected net loss. Shortly after, the company presented research at the International Society of Liquid Biopsy Congress, confirming strong analytical performance for its updated RaDaR® molecular residual disease assays and advances in liquid biopsy technology across solid...

Ingevity Corporation recently reported third-quarter 2025 results, with net income of US$43.5 million compared to a net loss a year ago, and announced the sale of its industrial specialties business for US$110 million expected to close in early 2026. Although the company posted stronger performance in Performance Materials and generated significant free cash flow, it also revised its full-year guidance downward due to competitive pressures and tariff impacts in the Advanced Polymer...

TEGNA (TGNA) has seen its stock move modestly this week, catching the attention of investors interested in steady media businesses. The company’s recent performance adds fresh context for those watching longer-term trends in the sector. See our latest analysis for TEGNA. TEGNA’s share price has delivered a steady climb so far this year, with a year-to-date price return of 6.23 percent. Its one-year total shareholder return stands at 8.9 percent. Although short-term moves have been modest,...

AtriCure (ATRC) shares were in focus after the company reported a surge in revenue for the third quarter of 2025 and sharply narrowed its net loss. The company also raised its full-year revenue guidance. See our latest analysis for AtriCure. Strong growth and reduced losses have caught investors’ attention lately, yet AtriCure’s momentum has faced headwinds, with a 1-day share price return of 1.75% following earnings but a 1-year total shareholder return of -14.4%. Recent medical trial news...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

H&R Block (HRB) released its first quarter earnings, reporting higher revenue and a narrower net loss compared to last year. The company also reaffirmed its full-year guidance, signaling continued confidence in its overall outlook. See our latest analysis for H&R Block. H&R Block’s recent earnings update and its decision to maintain a steady dividend have not managed to reverse the prevailing negative momentum, with the 1-year total shareholder return now sitting at -13.7% and the share price...

Investors in Definitive Healthcare Corp. ( NASDAQ:DH ) had a good week, as its shares rose 5.8% to close at US$2.93...